An observational study in Postoperative Complication and Recovery, Physiological, sponsored by University Hospital, Angers. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by University Hospital, Angers · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Postoperative Complications with a site in France — 7 open to participants now, 8 under way, 2 of them phase 3. Postoperative Complications · France.
Among the 64 studies in Postoperative Complications with a site in France, this one is the 19th largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2025, is one of 32 observational ones, and was the 57th registered.
1,335 studies on the registry are indexed under Postoperative Complications; 309 are open to participants now.
Browse Postoperative Complications studies →7 of the 64 studies in Postoperative Complications with a site in France are open now. Recruiting first, the newest first:
Zealand Pharma · Sites in France, United States, Austria and 11 more countries
Ages 18–90
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–80
University Hospital, Montpellier · Sites in France
Ages 18+
University Hospital, Tours · Sites in France
Ages 18+
Nantes University Hospital · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 200 Postoperative Complications studies recruiting now, 125 (63%) set no upper age limit and 32 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 7 started in 2025.
This study's planned enrollment of 200 is below the median of 251 across 538 observational studies indexed under Postoperative Complications.
Median enrollment 142 across the 32 interventional studies, 260 across the 32 observational. Of the 44 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 64 have an industry lead sponsor. The 10 most frequent:
University Hospital, Angers is the lead sponsor of 478 studies on the registry; 120 are open to participants now.
University Hospital, Angers has 5 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
3 of the studies in Postoperative Complications with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06675097University Hospital, AngersAssessment of the Impact of Intestinal Gas Emission Quality on the Postoperative Course After Abdominal Surgery | 2027-01-31 |
| NCT05525312University Hospital, MontpellierComparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery. | 2027-03-20 |
| NCT06351475Assistance Publique - Hôpitaux de ParisEfficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy | 2027-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 64 studies in Postoperative Complications with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The recovery of transit after surgery is an important parameter in postoperative evaluation. It generally reflects simple postoperative outcomes and allows the patient to return home.
The quality of gas recovery after surgery has not been studied to our knowledge, but it is not uncommon for an operated patient to emit some gas considered as a recovery of transit when it is ultimately a false transit preceding a postoperative ileus. Furthermore, intestinal gases and their composition reflect the intestinal microbiota. This microbiota has been shown to be predictive of the appearance of an operative complication. As the analysis of this microbiota cannot be carried out routinely, it is important to be able to use a reflection of this microbiota in routine practice and to correlate it with the surgical outcomes. Intestinal gas therefore seems to be the tool of choice.
The main objective is to evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.
The secondary objectives are to compare the quantity and quality of gases pre- and post-operatively and to define a predictive score for surgical complications, based on the number and quality of post-surgical gases.
Data regarding gas transit are collected by the patient in a questionnaire the two days before the surgery and until the patient leaves hospital (or until day 15 post-operative if the patient is still hospitalized).
Data regarding possible complications ((defined according to Dindo-Clavien as any deviation from the expected postoperative outcomes within 90 days following surgery) are collected throughout the hospital stay (day 0 : surgery to day 15 post-operatively), during the post-operative consultation (day 30) and during a telephone call to the patient (day 90).
The expected results are to highlight a correlation between the quality/quantity of gases and post-operative outcomes. A predictive score for complications could then be proposed and validated during this study.
The patients will be included in the hospital they will be operated on
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Non Inclusion Criteria:
Exclusion Criteria:
-Immediate post-operative intensive care with patient intubation
To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.
Operative complication is defined according to Dindo-Clavien as any deviation from the expected postoperative outcomes within 90 days following surgery. Complications are then classified according to the Dindo-Clavien classification from 1 (simplest) to 5 (death).
Time frame: From Day 0 (surgery) to the 90 post-operative days +/- 15 days.
To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.
The resumption of gas transit will be defined as the emission of gas for at least 2 days in a row. • The quantity corresponds to the number / 24 hours of gas
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized.From Day 0 (surgery) to the 90 post-operative days +/- 15 days.
To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.
The resumption of gas transit will be defined as the emission of gas for at least 2 days in a row. • The quality is defined by: * Single or multiple over the same time * Noisy or soundless * Dry or wet (no stools but mucus or transparent liquids) * Accompanied by stools * Non-odorous, slightly odorous, very smelly * Painful before the show * Relief after emission
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized.From Day 0 (surgery) to the 90 post-operative days +/- 15 days
to compare the quantity of gas pre- and post-operative
• gas quantity corresponds to number/24 H of gas (data are daily collected by the patient in a questionnaire)
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized
to compare the quantity of stools pre- and post-operative
• Stoll quantity corresponds to number/24 H of stool (data are daily collected by the patient in a questionnaire)
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized
to compare the quality of gases pre- and post-operative
• Gas quality is defined by : * Single or multiple over the same time * Noisy or soundless * Dry or wet (no stools but mucus or transparent liquids) * Accompanied by stools * Non-odorous, slightly odorous, very smelly * Painful before the show * Relief after emission .Data from gas are daily collected by the patient in a questionnaire.
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized
to compare the quality of stool pre- and post-operative
•stool quality is defined by the Bristol scale (type 1: separate hard lumps (severe constipation); type 2: lumpy and sausage-like (mild constipation); type 3: sausage shape with cracks (normal); type 5: soft blobs with clear-cut edges (lacking fiber); type 6: mushy consistency with ragged edges (mild diarrhea); type 7: liquid consistency with no solid pieces (severe diarrhea). .data are daily collected by the patient in a questionnaire
Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Jan 2027, 24 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 24 months is close to that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.